Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of ivabradine on vascular function in individuals at increased cardiovascular risk
2012-000215-89Phase 2Terminated
- Sponsor
- Servier
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac morbidity comparing Ivabradine with Placebo (2 arms). Primary endpoint: Absolute percentage change in flow-mediated dilation (FMD) of the brachial artery at 12 weeks. Started Apr 2013; status: terminated.
02
Drugs
ivabradine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2012-000215-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000215-89.